Wedbush upgraded shares of Healthpeak Properties (NYSE:DOC – Free Report) from a neutral rating to an outperform rating in a research report released on Friday morning, MarketBeat reports.
Other research analysts also recently issued research reports about the stock. Mizuho restated a buy rating and set a $22.00 price target on shares of Healthpeak Properties in a research report on Monday, April 22nd. BNP Paribas upgraded shares of Healthpeak Properties from a neutral rating to an outperform rating and upped their price target for the stock from $19.00 to $21.00 in a research report on Friday, April 26th. Wells Fargo & Company initiated coverage on shares of Healthpeak Properties in a research report on Monday, March 25th. They set an equal weight rating and a $19.00 price target for the company. StockNews.com cut shares of Healthpeak Properties from a hold rating to a sell rating in a research note on Friday, April 26th. Finally, Royal Bank of Canada upped their price objective on shares of Healthpeak Properties from $21.00 to $22.00 and gave the company an outperform rating in a research note on Wednesday, April 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of Hold and an average price target of $18.50.
Read Our Latest Stock Analysis on DOC
Healthpeak Properties Price Performance
Healthpeak Properties Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 17th. Stockholders of record on Monday, May 6th will be paid a $0.30 dividend. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $1.20 annualized dividend and a dividend yield of 6.33%. Healthpeak Properties’s dividend payout ratio is 342.87%.
Institutional Trading of Healthpeak Properties
Hedge funds have recently made changes to their positions in the company. Parallel Advisors LLC grew its stake in shares of Healthpeak Properties by 274.6% in the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after buying an additional 2,985 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Healthpeak Properties by 42.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock worth $70,000 after acquiring an additional 1,712 shares during the last quarter. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $124,000. Quadrant Capital Group LLC lifted its holdings in shares of Healthpeak Properties by 645.4% in the 4th quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock worth $128,000 after acquiring an additional 8,352 shares during the last quarter. Finally, Stratos Wealth Partners LTD. acquired a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $134,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is the NASDAQ Stock Exchange?
- 3 Value Stocks You Can Buy Before They Become Big
- Basic Materials Stocks Investing
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.